[ Price : $8.95]
GSK and Spero Therapeutics report positive Phase 3 results for tebipenem HBr, an investigational oral antibiotic for complicated u...[ Price : $8.95]
FDA says it is strengthening labeling for tranexamic acid injection products to clarify that it is only to be administered intrave...[ Price : $8.95]
FDA contracts with the Institute for Safe Medication Practices for services to strengthen its ability to identify and reduce the r...[ Price : $8.95]
FDA hosts a one-day public workshop 10/23 to explore new approaches for approving patch test allergens used in diagnosing allergic...[ Price : $8.95]
FDA accepts for review a Replimune BLA resubmission for RP1 (vusolimogene oderparepvec) in combination with nivolumab for treating...[ Price : $8.95]
Roche reports new favorable data from the Phase 3 evERA Breast Cancer study of its investigational oral therapy giredestrant, used...[ Price : $8.95]
Attorneys at Hyman, Phelps & McNamara say they are encouraged by an FDA draft guidance outlining a roadmap for postapproval monito...[ Price : $8.95]
The Advanced Medical Technology Association outlines a series of recommendations aimed at strengthening U.S. leadership in medical...